Skip to main content

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in CRL — Charles River Laboratories International, Inc.

CIK 1164508 BOSTON, MA

Position in CRL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$63,174,168
-$63,963,507 QoQ
Shares Held
278,558
-62.2% QoQ
Ownership
0.584%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#44
of 570 holders
Holding Since
Jun 2020
9 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in CRL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $3,756,493,842 across 20 Diagnostics & Research names. CRL ranks #11 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRL

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $63,174,168 278,558
2026-03-31 $127,137,675 737,030
2025-12-31 $166,813,155 836,240
2025-09-30 $120,386,113 769,437
2025-06-30 $87,792,343 578,609
2025-03-31 $53,221,162 353,582
2021-12-31 $17,671,358 46,901
2021-09-30 $19,808,160 48,000
2020-06-30 $488,180 2,800